GlaxoSmithKline Consumer Healthcare Ltd records 7% growth for Q3, FY 2016

Press Release
New Delhi, Feb 08 2016

GlaxoSmithKline Consumer Healthcare Ltd records 7% growth for Q3, FY 2016

Financial Highlights:

  • Gross Sales rise by 7%
  • Profits up by 37%

Overview

GlaxoSmithKline Consumer Healthcare Limited today declared its financial results for the third quarter ended December 31, 2015. Gross sales at Rs 1100 crores recorded a growth of 7 % with PAT at Rs. 132 crores growing by 37 % for the same period and PBT at Rs 203 crores growing by 37 %.

Commenting on the results, Mr. Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are happy to declare our results for the third quarter where we have been able to gain share in the HFD category. We have been able to successfully connect and engage with our consumers via sharp insight based communication to grow consumption of Horlicks. Our core differentiator remains our science and we will strengthen our focus to constantly innovate. Today our products continue to be available at affordable price points, reaching a larger consumer base across the country in both rural and urban markets.”

Performance Highlights

  • Access agenda driven by increased expansion and fast growth in distribution
  • Mothers Horlicks & Horlicks Lite continue to grow at strong double-digit growth
  • Strong bottom line driven by gross margin

 Health Food Drinks

  • Our health drink portfolio continues to be a market leader with 59.1% (Value share) and 67.3% (Volume share) – (MAT Dec, 2015)
  • Horlicks and Boost among the top 3 HFD brands
    • Horlicks at 47.2 % Value share and 53.5 % Volume share(MAT Dec, 2015)
    • Boost at 11.5% Value share and 13.3 % Volume share (MAT Dec, 2015)
  • Horlicks continued on its strategy of driving consumption in its core markets of South and East by activating a new campaign, addressing the evening consumption.
  • For Boost, a new sachet campaign “Har Chhote Dhoni Ke Liye Chhota Boost” – generated excitement and has been well received.

About GlaxoSmithKline Consumer Healthcare Ltd

 GSK Consumer Healthcare Ltd is the category leader in Indian health food drinks industry. Our flagship product Horlicks leads the market, while Boost is among the top three health food drink brands that India prefers. Our manufacturing plants are located in Nabha, Rajahmundry and Sonepat. In India we have an engaged workforce of over 3500 employees. GSK also markets and distributes a range of everyday health products such as Eno, Crocin, Iodex and Sensodyne. Our marketing and distribution network comprises over 700 distributors and a direct coverage of over 8 lakh retail outlets.

GSK Consumer Healthcare Ltd is an associate of GlaxoSmithKline plc.of U.K, one of world’s largest consumer healthcare companies. We have a heritage that goes back over 160 years. Our purpose is to help more people around the world to do more, feel better and live longer with everyday healthcare products.  Our goal is to build a global, growing business - we call a Fast Moving Consumer Healthcare (FMCH) company - dedicated to everyday healthcare with all of the scientific expertise and quality guarantees that demands, working at the speed and with the genuine consumer understanding the modern world expects.

GSK Consumer Healthcare globally owns some of the world’s best loved healthcare brands, successful in over 100 countries. These include Sensodyne, Voltaren, Theraflu, Paradontax, Panadol, Polident, Otrivin, Horlicks and Physiogel.

Media Contacts

Genesis Burson-Marsteller

Sakshi Mathur: sakshi.mathur@bm.com /+91 9999007585

M  Sindhu: m.sindhu@bm.com /+91 9899428304

GlaxoSmithKline Consumer Healthcare

Deepa Dey: deepa.d.dey@gsk.com